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Abstract
Background
KwaZulu-Natal province, South Africa, has among the highest burden of XDR TB worldwide
with the majority of cases occurring due to transmission. Poor access to health facilities can
be a barrier to timely diagnosis and treatment of TB, which can contribute to ongoing trans-
mission. We sought to determine the geographic distribution of XDR TB patients and prox-
imity to health facilities in KwaZulu-Natal.
Methods
We recruited adults and children with XDR TB diagnosed in KwaZulu-Natal. We calculated
distance and time from participants’ home to the closest hospital or clinic, as well as to the
actual facility that diagnosed XDR TB, using tools within ArcGIS Network analyst. Speed of
travel was assigned to road classes based on Department of Transport regulations. Results
were compared to guidelines for the provision of social facilities in South Africa: 5km to a
clinic and 30km to a hospital.
Results
During 2011–2014, 1027 new XDR TB cases were diagnosed throughout all 11 districts of
KwaZulu-Natal, of whom 404 (39%) were enrolled and had geospatial data collected. Partic-
ipants would have had to travel a mean distance of 2.9 km (CI 95%: 1.8–4.1) to the nearest
clinic and 17.6 km (CI 95%: 11.4–23.8) to the nearest hospital. Actual distances that partici-
pants travelled to the health facility that diagnosed XDR TB ranged from <10 km (n = 143,
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36%) to >50 km (n = 109, 27%), with a mean of 69 km. The majority (77%) of participants
travelled farther than the recommended distance to a clinic (5 km) and 39% travelled farther
than the recommended distance to a hospital (30 km). Nearly half (46%) of participants
were diagnosed at a health facility in eThekwini district, of whom, 36% resided outside the
Durban metropolitan area.
Conclusions
XDR TB cases are widely distributed throughout KwaZulu-Natal province with a denser
focus in eThekwini district. Patients travelled long distances to the health facility where they
were diagnosed with XDR TB, suggesting a potential role for migration or transportation in
the XDR TB epidemic.
Introduction
Tuberculosis (TB) remains a major health burden globally [1], with 10.4 million cases esti-
mated to have occurred in 2015 [2]. South Africa has the sixth highest burden of TB in the
world (estimated 454,000 cases), and the second highest estimated incidence (834 per 100,000
population) [2]. Extensively drug resistant tuberculosis (XDR TB) is defined as resistance to at
least isoniazid, rifampicin, a fluoroquinolone and a second-line injectable drug, the most effec-
tive first- and second-line drugs for treating TB. XDR TB has been reported in 105 countries
and South Africa has the highest prevalence of XDR TB in sub-Saharan Africa [2, 3]. Within
South Africa, KwaZulu-Natal province has among the highest burden of XDR TB, with 1,596
diagnosed cases in 2012 [4–6] and high rates of HIV co-infection (>90% among XDR TB
patients) [7].
Drug-resistant TB is characterized by delayed diagnosis, in part due to policies that restrict
drug-susceptibility testing. Treatment success rates are low. Consequently, patients experience
prolonged infectious periods, which increases the risk of ongoing transmission to others.
Delays in diagnosis also place patients at risk for clinical decline and increased mortality rates,
particularly in the setting of HIV co-infection [7, 8]. Furthermore, adults suffering from TB
lose several months of working time, resulting in a decrease in household income [9], further
underscoring the need for early diagnosis and initiation of effective treatment. However, both
are dependent on the access that individuals have to health facilities offering appropriate TB
diagnosis and treatment services.
Access to health services is difficult to define because it encompasses several factors, includ-
ing quality of care or service, geographical accessibility, suitability of available services and
financial constraints of patients and health systems. Of these, geographic accessibility is a cru-
cial barrier to individuals accessing health facilities and is important to understand as pro-
grams expand TB services. Several studies in developing countries have provided evidence that
physical proximity of healthcare services can play an important role in the use of healthcare
facilities [10–12]. Recent advances in geographical information systems (GIS) software that
facilitate distance-based measures focused on distance and travel time have led to more accu-
rate analysis of driving distance and travel time based on actual road networks[13, 14].
This study aimed to describe the geographic distribution of patients with XDR TB in rela-
tion to health facilities. Specifically, we sought to assess ease of access based on travel times and
distances to the closest health facility, as well as to the actual health facility at which XDR TB
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was diagnosed. This analysis provides an understanding of the availability and utilisation of
public healthcare services among XDR TB patients throughout the province.
Materials and methods
Study area
KwaZulu-Natal province comprises 11 districts (Fig 1) and has a population of 10.3 million
persons, 53% of whom reside in rural areas[15]. KwaZulu-Natal harbours nearly half of South
Africa’s XDR TB burden and has more than 1.6 million people living with HIV. The province
has 56 hospitals and 562 clinics [16] whose distribution mirrors the overall population distri-
bution, with 57% located in rural areas[15]. A single referral laboratory conducts drug-suscep-
tibility testing (DST) for all public healthcare facilities in the province, allowing for capture of
all diagnosed XDR TB cases.
Study subjects and data collection
The study prospectively enrolled culture-confirmed XDR TB patients diagnosed from May
2011 through August 2014, residing in KwaZulu-Natal. All newly diagnosed XDR TB cases
were eligible for the study. The only exclusion criterion was residence outside of KwaZulu-
Fig 1. Distribution of all XDR TB cases diagnosed per health facility (left panel) and enrolled XDR TB cases per health facility and
residential location (right panel), KwaZulu-Natal, 2011–2014.
https://doi.org/10.1371/journal.pone.0181797.g001
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Natal province. The goal of the study was to enroll a convenience sample of 400 XDR TB par-
ticipants. All diagnosed patients were referred to study staff who, in collaboration with the
diagnosing clinic, contacted the patient and introduced the study. Patients interested in
participating were met at their current location (e.g., home, hospital) where they underwent
informed consent. For children, parental consent and assent for the child was obtained; for
deceased or severely ill participants, consent was obtained from next-of-kin. The geographic
representativeness of enrolled participants was tested by comparing the proportion of cases
enrolled among XDR TB patients diagnosed from each district using a chi-square test. Addi-
tionally, representativeness based on age and sex was assessed in a subgroup of individuals
diagnosed in 2011 and 2012 and tested by Wilcoxon Rank Sum and chi-square tests. Full
details of study enrolment and data collection have been previously published.[17]
Among consented participants, interviewers collected information about socio-demo-
graphics, TB and HIV history, and location and duration of all hospitalisations in the preced-
ing 5 years. A global position system (GPS) coordinate location was collected at each
participant’s home and the diagnosing facility was identified as the clinic or hospital from
which the specimen that grew XDR TB was submitted to the provincial lab.
Analysis of distance to closest healthcare facility and diagnosing facility
ArcGIS Network Analyst is an extension within ArcGIS1 software [18] that allows users to
model realistic road network conditions by incorporating road network data, lengths of road
segments, speed limits, turn restrictions and vehicle height restrictions. Network Analyst uses
Dijkstra’s Algorithm to solve routing problems, which is based on distance and time criteria
[19]. The assumption made in this analysis is that travel to specified locations is along the
shortest route in the network. Estimated travel times and distances do not account for delays
which may be encountered along the road network for various reasons.
Travel distances of study participants were determined to the nearest clinic and hospital.
Road network data including road classes were utilised for this analysis [20]. The “closest facil-
ity” tool was used to obtain distance and the “origin-destination (OD) matrix” tool was used to
obtain time, both tools available within the ArcGIS1 Network Analyst extension. The closest
facility tool measures the time of traveling between incidents (location of study participants)
and facilities (health facilities) and determines which are nearest to one other. The OD cost
matrix finds the least-cost path (measured by time) from each origin to the nearest specified
destination. Different speeds were assigned to various road classes within the network; speed
assigned per segment was determined by the KwaZulu-Natal Department of Transport regula-
tions [21]. Table 1 shows the hierarchy of road classes and their associated speeds.
The quality of road network data is crucial to the analysis providing accurate results, there-
fore care was taken to ensure that all polylines comprising the network did not overlap, were
not duplicated, and did not have breaks in connectivity (end points of lines that are not joined
Table 1. Road classes and road speeds in KwaZulu-Natal province, as defined by the KwaZulu-Natal
Department of Transport.
Road classification Movement network Speed (km/h)
Regional distributor Vehicle-only route 120
Primary distributor Vehicle-only route 100
District distributor Mixed pedestrian and vehicle route 80
Local distributor Mixed pedestrian and vehicle route 60
Access street Mixed pedestrian and vehicle route 40
https://doi.org/10.1371/journal.pone.0181797.t001
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to other lines in the network). Data cleaning and quality checking was conducted using a suite
of geoprocessing tools within ArcGIS1.
Residential location of the participant and location of the health facility that sent the diag-
nostic XDR TB sputum were both known for participants enrolled into the study, and were
used to determine actual travel distance and time per participant. The locations of health facili-
ties to which study participants reported were considered in relation to the cleaned, coded pro-
vincial road network in KwaZulu-Natal, with road features divided into four main classes:
regional, primary, district and local [21]. The travel distance and time from the participant’s
residence to the actual health facility at which he/she presented was calculated using the Arc-
GIS1 “XY to Line” tool.
Ethical considerations
Written informed consent was obtained from all participants. For children under age 18, con-
sent was obtained from a parent or guardian, with additional assent obtained for children over
age 7. For deceased or severely ill participants, consent was obtained from next-of-kin.
The study was approved by the Institutional Review Boards of Emory University, Albert
Einstein College of Medicine, and the University of KwaZulu-Natal, and by CDC’s National
Center for HIV, Hepatitis, STDs and Tuberculosis.
Results
A total of 1,027 XDR TB cases were diagnosed at health facilities in KwaZulu-Natal between
2011 and 2014, of which 521 (51%) were screened and 404 (38%) were enrolled into the study.
Enrolled cases were distributed across all eleven districts in the province and were representa-
tive of the overall diagnosed XDR TB cases geographically, by age and sex (p = 0.70, 0.52 and
0.76, respectively; Fig 1).
Participants would have had to travel a mean distance of 2.9 km (CI 95%: 1.8–4.1) to the
nearest clinic and 17.6 km (CI 95%: 11.4–23.8) to the nearest hospital (Table 2). Participants
enrolled from the predominantly rural districts of uThukela (69.7% rural; 38.9km), uMkha-
nyakude (94.4% rural; 20.2km), Ugu (82.4% rural; 23.1km) and Sisonke (79.7% rural; 24.6km)
would have had to travel the farthest distance to their nearest hospital, all greater than the
Table 2. Mean travel distance and time to the nearest clinic, nearest hospital and the facility that diagnosed XDR TB, by district.
District n Travel distance
to nearest
facility (kms)
Travel time to
nearest facility
(hrs)
Proportion
Population
Travel distance to actual facility
(kms)
Travel time to actual facility
(hours)
Clinic Hospital Clinic Hospital Urban Rural
Sisonke 6 6.37 24.55 0.08 1.02 20.3 79.7 119.93 1.50
Zululand 31 4.89 17.36 0.12 0.80 19.5 80.5 72.12 0.90
uMkhanyakude 22 3.63 20.24 0.12 2.86 5.6 94.4 89.91 1.12
uMzinyathi 65 3.63 14.42 0.11 1.16 17.4 82.6 42.99 0.54
Uthungulu 36 2.82 9.5 0.05 2.05 18.1 81.9 201.37 2.52
uThukela 17 2.73 38.87 0.08 0.85 30.3 69.7 50.73 0.63
Ugu 37 2.47 23.06 0.05 1.43 17.6 82.4 174.54 2.18
uMgungundlovu 39 2.23 18.9 0.06 0.25 58.1 41.9 36.11 0.45
iLembe 15 2.09 9.32 0.04 1.81 36.5 63.5 45.59 0.57
Amajuba 5 0.74 11.6 0.27 0.95 55.3 44.7 201.39 2.52
eThekwini 131 0.49 6 0.01 0.73 84.8 15.2 19.57 0.24
TOTAL 403 2.31 13.98 0.06 1.11 33 67 68.98 0.86
https://doi.org/10.1371/journal.pone.0181797.t002
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overall provincial mean. The guidelines provided by the Council for Scientific and Industrial
Research (CSIR) for the provision of social facilities in South Africa sets the acceptable travel
distance at 5 km to a clinic and 30 km to a hospital[22]. Two districts exceeded this recommen-
dation, with participants in Sisonke residing an average travel distance of 6.4 km from the
nearest clinic and participants in uThukela residing 38.9 km away from the nearest hospital
(Table 2).
Mean distances that study participants actually travelled to the diagnosing health facility are
described for each of the 11 districts and 47 municipalities in KwaZulu-Natal in Fig 2. Study
participants residing in Amajuba, Uthungulu, Sisonke and Ugu districts travelled the farthest,
on average, to the facility at which they were diagnosed (>100 km). Participants in Ukhanya-
kude, Zululand and Uthukela also travelled large distances (50-100km), while those in the
central districts (Umzinyathi, Umgungundlovu and eThekwini) travelled the lowest mean dis-
tances (>10-50km). The highest proportion of patients seeking care outside their district of
residence (>60%) came from Sisonke, iLembe and Amajuba districts (83%, 80% and 67%,
respectively).
Fig 2. Mean actual distance travelled by participants to the health facility at which XDR TB was diagnosed, mean distance
travelled farther than the nearest clinic, and proportion that sought care outside their district and municipality of residence,
districts and municipalities of KwaZulu-Natal, 2011–2014.
https://doi.org/10.1371/journal.pone.0181797.g002
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Of the 404 participants, 111 (28%) reported to facilities outside their district of residence,
and 185 (46%) reported to a health facility in the eThekwini District; 36% of these (16% of
all enrolled cases) originated outside of the Durban metropolitan area, but were diagnosed
with XDR TB in Durban. Actual distances that participants travelled to the health facility at
which they were diagnosed ranged from < 10 km (n = 143, 36%) to> 50 km (n = 109, 27%)
(Table 3).
The average travel distances significantly exceed the distances that individuals would have
had to travel to the facility nearest to their homes. A spider plot illustrating straight-line dis-
tances between participant residence and the facility at which they were diagnosed further
confirmed that study participants sought care at health facilities distant from their place of res-
idence (Fig 3). The majority (77%) of participants travelled farther than the recommended dis-
tance to a clinic (5 km) and 39% travelled farther than the recommended distance to a hospital
(30 km).
Discussion
South Africa is experiencing a widespread epidemic of XDR TB, and has among the highest
rates of XDR TB worldwide. We have previously shown that the majority of XDR TB cases
occur due to person-to-person transmission of XDR TB strains [23]. Prolonged infectious
periods in XDR TB patients may be caused by delayed diagnosis, delayed treatment, or both,
which leads to ongoing transmission. In the current study, we assessed the distance to the diag-
nosing health facility in a cohort of patients with XDR TB and found that a large proportion
had sought health care outside their district of residence, with 27% traveling over 50km to a
facility for XDR TB diagnosis. Almost half (46%) of participants were diagnosed at a health
facility in eThekwini district, of whom 36% resided outside the Durban metropolitan area.
Together, these findings suggest an important role for within-province travel for healthcare in
the ongoing XDR TB epidemic.
A major strength of this study is that it enrolled participants from all 11 districts in Kwa-
Zulu-Natal province and used the most up-to-date road network data to model travel times
and distances. Furthermore, road network analysis was conducted using GPS coordinate loca-
tion of the participant’s residential address in relation to both the physical location of health
facilities in closest proximity, and the physical location of the actual facility that sent the diag-
nostic XDR TB sputum. Similar studies have attempted to model accessibility of health care
facilities using road networks in South Africa. Tanser, Gijsbertsen [24] collected data on meth-
ods of accessing health care from 23,000 homesteads in Hlabisa municipality within uMkha-
nyakude district. They found that the average travel times using public transport were 81 and
170 minutes to a clinic and hospital, respectively. However, the study did not calculate travel
distance and it was limited to one district in KwaZulu-Natal province. Nteta, Mokgatle-Nthabu
Table 3. Actual distance travelled by participants (n = 404) to the health facility at which XDR TB was
diagnosed, KwaZulu-Natal, 2011–2014.
Actual Distance Travelled n %
>200 km 21 5.22
100–200km 36 8.96
50–100 km 52 12.94
30–50 km 47 11.69
10–30 km 103 25.62
5–10 km 49 12.19
<5 km 94 23.38
https://doi.org/10.1371/journal.pone.0181797.t003
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[25] did not undertake road network analysis, but surveyed participants who attended three
community health centres (CHCs) in Gauteng province. Their findings revealed that a large
proportion of respondents (71%) travelled 30 minutes or less to the nearest clinic and a smaller
proportion (24%) travelled distances between 30 minutes and an hour. The results of their dis-
tance analysis found 45% of study participants travelled less than 5km and 39% travelled 5 to
10km. However, that study did not model travel based on road networks, the sample size was
smaller (235 participants) and it was confined to a single district (Tshwane).
Fig 3. Spider plot showing straight line distance from participants’ residence to the health facility at which they presented
that diagnosed XDR TB, KwaZulu-Natal, 2011–2014.
https://doi.org/10.1371/journal.pone.0181797.g003
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We found that study participants would have had to travel 2.9 km and 13.9 km, on average,
from their residence to the nearest public health clinic and hospital, respectively. However,
they travelled an average of 69 km to the actual facility (both clinics and hospitals combined)
that diagnosed XDR TB disease. This distance significantly exceeds the average distance
reported in Tshwane district of between 5 and 10 km [25]. The mean time to the health facility
was found to be 1.2 hours, considerably greater than the mean time of 30.7 minutes reported
by Harris, Goudge [26] who aimed to assess inequalities in access to healthcare in South Africa.
Districts with large proportions of their population living in rural areas had longer travel dis-
tances for participants, both to their nearest facility and to the facility at which they actually
presented. Access to public transportation and poor quality of road networks may contribute
to increased travel distance and time to health facilities in rural areas.
Study participants travelled substantially farther than their nearest facilities to seek care.
Reasons for this health seeking behaviour are likely to vary, and may include patients seeking
care in areas where they are employed instead of where they reside; patients seeking care at
hospitals in urban areas that are perceived to have favourable reputations in communities;
patients wanting to seek care at facilities that provide better quality of care in terms of available
treatments, facilities, medication and staff; as well as patients wanting to use health care facili-
ties that have a shorter waiting time and queues [26]. Other factors that could be contributing
to patients travelling long distances for care could be the stigma associated with TB in South
Africa[27–29]. Whatever the reasons for seeking care at facilities farther away, time losses
resulting from travelling long distances are a potential threat to TB diagnosis, treatment initia-
tion and retention, all of which contribute to ongoing transmission [30].
Long travel distances to access public health care has additional consequences of greatly
increasing the possibility of transmission of XDR TB at the community level. Among study
participants who reported regularly traveling long distances in the months preceding their
XDR TB diagnosis, 80% (44 of 55) reported using public transportation when traveling; these
modes of transportation included combis, taxis or buses that are crowded, poorly-ventilated
vehicles. In addition, although not directly measured, patients are likely to have sought care at
their local health facility before traveling to a farther facility for XDR TB diagnosis and care.
Taken together, each patient with XDR TB may be spending a minimum of 2–4 hours travel-
ing to and from health facilities while infectious (i.e., before a diagnosis is made and effective
treatment is started), creating numerous opportunities for transmission en route.
Our results showed that 43% of the enrolled participants sought health care at eight special-
ised TB hospitals that are provincial facilities; the remainder were distributed between stan-
dard hospitals and clinics, mobile clinics and community health centres. These specialised
hospitals serve communities with an elevated incidence of TB and they provide long-term
inpatient care for patients with chronic TB. However, the fact that only eight such facilities
provincially reported the plurality of the XDR TB cases highlights the shortage of these
specialised facilities, perhaps a factor compelling patients to travel long distances. New rapid
molecular diagnostics for drug resistance that are situated closer to patients, combined with
decentralized models of care may reduce delays in diagnosis and treatment, and reduce trans-
mission [31, 32].
A limitation of this study was that all participants were assumed to have access to either
public or private modes of transport, which might not have been the case. We also calculated
uninterrupted travel along the roads to obtain travelled distances and time. Therefore, we did
not account for any factors that would affect flow of traffic or slow vehicles down. Distances
were calculated from a single home address, which may not represent the starting point for
travel to all health facilities in this population. Furthermore, we did not obtain qualitative
information from participants about their reasons for seeking health care far from their
Spatial distribution of XDR TB patients in KwaZulu-Natal, South Africa
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residence; nor did we compare the capacity for providing adequate care at the closest clinic or
hospital to the capacity at the actual diagnosing facility. However, the primary capacity that
would be needed is clinical suspicion for TB, and sputum sample collection and transport
for drug resistance testing at a referral laboratory. Lastly, persons who have even longer
travel distances and less access to health facilities are less likely to have been diagnosed with
XDR TB. These persons would not eligible for inclusion in this study; therefore, our estimates
of the distance and time travelled for XDR TB diagnosis in the study population may be an
underestimate.
Transmission of XDR TB is driving the epidemic in South Africa. Our findings demon-
strate the long distances a large proportion of patients travelled for care that correctly diag-
nosed XDR TB. The role of migration has been well-studied and documented for the HIV
epidemic in South Africa, but far less is known about the impact of migration on TB and XDR
TB transmission. As people move for work, school, family or health reasons throughout Kwa-
Zulu-Natal, a better understanding of where transmission is occurring can help guide inter-
ventions aimed at halting ongoing XDR TB spread.
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